Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

PAI
FDA Approves BUPRENORPHINE HYDROCHLORIDE — PAI Holdings, LLC dba PAI Pharma

PAI Holdings, LLC has received FDA approval for its ANDA for buprenorphine hydrochloride, solidifying its position in the critical opioid addiction tr...

Kenvue
FDA Approves ZYRTEC ALLERGY — Kenvue Brands LLC

Kenvue Brands LLC received regulatory affirmation regarding ZYRTEC ALLERGY, a widely used oral tablet containing cetirizine hydrochloride that has cem...

INDIVIOR
FDA Approves SUBOXONE — INDIVIOR INC.

INDIVIOR INC. confirmed on Tuesday that Approval for buccal buprenorphine and naloxone (SUBOXONE) was granted on August 30, 2010, signaling a pivotal ...

Merz
FDA Approves XEOMIN — Merz Pharmaceuticals, LLC

On July 30, 2010, Merz Pharmaceuticals, LLC received FDA approval for XEOMIN (incobotulinumtoxin A), signaling a new entrant in the botulinum toxin ty...

AMNEAL
FDA Approves Unknown Drug — AMNEAL

On July 16, 2010, Amneal Pharmaceuticals received FDA approval for new drug application 090606, a strategic move that positions the firm to expand its...

Amneal
FDA Approves SPIRONOLACTONE — Amneal Pharmaceuticals LLC

Amneal Pharmaceuticals announced the FDA approval of generic Spironolactone, offering a bioequivalent oral treatment option. This approval adds signif...

Knoa
FDA Approves BUTRANS — Knoa Pharma LLC

Knoa Pharma LLC secured FDA approval for its BUTRANS transdermal patch, expanding the market for long-acting opioid delivery systems in the chronic pa...

VistaPharm,
FDA Approves METHADONE HYDROCHLORIDE — VistaPharm, LLC

VistaPharm, LLC received FDA approval on June 30, 2010, for the 10 mg and 40 mg tablets of Methadone Hydrochloride (ANDA090707) as a generic oral form...

ANI
FDA Approves Unknown Drug — ANI PHARMS

Moments ago, ANI PHARMS announced FDA approval for its generic version of the unnamed substance, expected to broaden the company’s revenue streams and...

Heritage
FDA Approves GLIPIZIDE AND METFORMIN HCL — Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. has secured approval for its generic version of GLIPIZIDE AND METFORMIN HCL, marking a d...

Strides
FDA Approves MYCOPHENOLATE MOFETIL — Strides Pharma Science Limited

Strides Pharma Science Limited announced the successful launch of oral Mycophenolate Mofetil (ANDA090055) to compete in this critical cardiovascular m...

Walgreens
FDA Approves ADAPALENE — Walgreens

Walgreens received FDA approval on June 2 for a generic topical acne treatment containing Adapalene, a move expected to intensify competition and pric...

Amgen,
FDA Approves PROLIA — Amgen, Inc

Amgen’s (NASDAQ: AMGN) approval of the subcutaneous DENOSUMAB formulation shows the biotech giant intends to leverage the format’s improved dosing con...

QUAGEN
FDA Approves VALPROIC ACID — QUAGEN PHARMACEUTICALS LLC

# FDA Approves Quagen Pharmaceuticals' Generic Valproic Acid Oral Formulation Quagen Pharmaceuticals LLC received FDA approval for its generic valpro...

Aurobindo
FDA Approves VALACYCLOVIR HYDROCHLORIDE — Aurobindo Pharma Limited

Aurobindo Pharma Limited received FDA approval for the generic oral formulation of valacyclovir hydrochloride, allowing the company to enter a high-re...

BARR
FDA Approves Unknown Drug — BARR

On May 7, 2010, Barr Pharmaceuticals received approval for ANDA090360, paving the way for an Abbreviated New Drug Application (ANDA) that targets the ...

Trigen
FDA Approves TRAMADOL HYDROCHLORIDE EXTENDED-RELEASE — Trigen Laboratories, LLC

Trigen Laboratories, LLC has secured FDA approval for its generic version of TRAMADOL HYDROCHLORIDE EXTENDED-RELEASE, the moisture-sensitive, oral for...

B.
FDA Approves CEFEPIME HYDROCHLORIDE AND DEXTROSE — B. Braun Medical Inc.

B. Braun Medical Inc. earned FDA approval today for Cefepime Hydrochloride and Dextrose Intravenous injection, a strategic addition to its hospital po...

EXELAN
FDA Approves TAMSULOSIN HYDROCHLORIDE — EXELAN PHARMACEUTICALS, INC.

Exelan Pharmaceuticals has received FDA approval for the ANDA087110, expanding its portfolio with the oral treatment Tamsulosisin Hydrochloride. This ...

NOVARTIS
FDA Approves Unknown Drug — NOVARTIS

Regulatory approval was granted by the FDA on April 20, 2010, for the drug developed by Novartis under NDA021560; this clearance is anticipated to bol...